Cardiac

According to the haemostatic agent’s review1 article, an ideal haemostatic agent would achieve haemostasis and show other potential benefits including:

better visualization of the surgical area, shorter operative times, decreased requirement for transfusions, better management of an anticoagulated patient, decreased wound healing time and overall improvement in patient recovery time”.

Based on self-assembling peptide technology, 3-D Matrix has obtained CE mark approval for the surgical haemostatic agent, PuraBond, which has multiple unique features that distinguish it from competitors and make it highly suitable for cardiac surgery.

Discover more about PuraBond

PuraBond is suitable for a variety of situations

  • PuraBond is scientifically-backed. Access the evidence here:
  • Watch PuraBond in action in a variety of cardiac procedures:
  • Hear from your peers who use PuraBond in their hospital:

Read our case reports

Read our case reports

Join us with the international experts:

PuraBond is indicated for haemostasis in the following situations encountered during surgery or endoscopic procedure, when hemostasis by ligation or stand means is insufficient or impractical: 2

  • Bleeding from small blood vessels and oozing from capillaries of the parenchyma and surrounding tissues of solid organic
  • Oozing from vascular anastomoses to native or artificial vessels, on the surface of blood vessels and surrounding tissues

Read more on PuraBond

1. Comparison of hemostatic agents used in vascular surgery; Krishna S. Vyas, Sibu P. Saha; Expert Opin Biol Ther. 2013 December; 13(12): 1663–1672.
2. PuraBond IFU-009 Rev 2 / IFU-014 Rev 2

Collaboration Opportunities

Our R&D teams are always exploring new innovations and indications to expand our products so that we continue providing healthcare professionals with better services and patient outcomes. If you are interested in collaborating with us, please get in touch.

Find out more
Discover peptides

Discover peptides

Learn more about PuraBond, its synthetic self-assembling peptide (SAP) composition, and the benefits this brings in practice.

About PuraBond

Scientifically-backed

Scientifically-backed

Our haemostatic hydrogels are continually supported by data from healthcare professionals across the globe.

See the evidence

Reach out

Reach out

With offices across Europe, Middle East, Americas, Asia and Australia, our team are committed to supporting you and your patients worldwide.

Find your local supplier